Assignee
CLARUS THERAPEUTICS INC
US·9 granted patents·22 pending applications·58 citations·filing 2012–2021
Top patents by PatentIndex Score
31 records- 0196US11331325B2Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2019·Granted May 17, 2022·4 cites·6 claims
- 0296US8828428B1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2014·Granted Sep 9, 2014·19 cites·4 claims
- 0395US11179402B2Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Granted Nov 23, 2021·5 cites·17 claims
- 0495US11179403B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·5 cites·27 claims
- 0590US10617696B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2016·Granted Apr 14, 2020·5 cites·1 claims
- 0690US10543219B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Granted Jan 28, 2020·5 cites·12 claims
- 0790US8778917B2Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2013·Granted Jul 15, 2014·7 cites·9 claims
- 0888US11426416B2Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2019·Granted Aug 30, 2022·1 cites·9 claims
- 0982US10245273B2Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agentsCLARUS THERAPEUTICS INC·Filed 2014·Granted Apr 2, 2019·7 cites·11 claims
- 1072US2019070196A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1169US2018021350A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1269US2018028542A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1369US2018078566A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1469US2020197413A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1569US2014296199A1Pharmaceutical delivery systems for hydrophobic drugs and compositions compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1669US2020197412A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1769US2018021351A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1866US2022088034A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1965US2013022674A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2065US2014274986A1Oral testosterone ester formulations and methods of treating testosterone deficiency comprising sameCLARUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2165US2021220374A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2263US2015343073A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2363US2016000806A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2463US2015343074A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2563US2015343072A1Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising sameCLARUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2658US2020054648A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2757US2014303129A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2854US2020038411A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2953US2017246184A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3051US2018333423A1Methods of treating testosterone deficiencyCLARUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3149US2020016172A1Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agentsCLARUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CLARUS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →